論文・技術情報追加のお知らせ

①A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS).

アバロパラチドの安全性評価研究

対象DB：FAERS

②Identification of novel signal of Raynaud's phenomenon with Calcitonin Gene-Related Peptide(CGRP) antagonists using data mining algorithms and network pharmacological approaches.

CGRP拮抗薬とレイノー現象との関連性調査研究

対象DB：FAERS

③Weight gain, gender and antipsychotics: a disproportionality analysis of the FDA Adverse event reporting System database (FAERS).

抗精神病薬による体重増加リスク調査研究

対象DB：FAERS

④Baclofen and Tizanidine Adverse Effects Observed Among Community-Dwelling Adults Above the Age of 50 Years: A Systematic Review.

高齢者における、バクロフェンとチザニジンの有害事象調査研究

対象DB：FAERS

⑤A pharmacovigilance study of adverse event profiles and hemorrhagic safety of bevacizumab based on the FAERS database.

ベバシズマブによる出血リスク調査研究

対象DB：FAERS

⑥The Awareness and Experience About Endoscopic Adverse Events Among South Korean Endoscopists.

韓国における、内視鏡手術に関連する有害事象調査研究

対象DB：KAERS

⑦Anaphylaxis due to antiallergic and antiasthmatic biologics.

抗アレルギー剤および抗喘息剤によるアナフィラキシーのリスク評価研究

対象DB：VigiBase

⑧Evaluation of time to onset and outcome of lung adverse events related to pembrolizumab using marketing surveillance.

ペムブロリズマブによる、肺に関連する有害事象の発症期間、転帰の調査研究

対象DB：JADER

⑨Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature.

オラパリブによる間質性肺疾患のリスク調査研究

対象DB：JADER